Xian He

Atezolizumab in combination with bevacizumab enhances antigen-specific T-cell migration in metastatic renal cell carcinoma

Jeffrey J. Wallin, Johanna C. Bendell, Roel Funke et al. · Nature Communications · 2016 · 690 citations · Full text

Tumor Biology, Tumor Immunology, Cancer Immunosurveillance +14

Phase Ib trial of atezolizumab in combination with nab-paclitaxel in patients with metastatic triple-negative breast cancer (mTNBC).

Sylvia Adams, Jennifer R. Diamond, Erika Hamilton et al. · Journal of Clinical Oncology · 2016 · 123 citations

Breast Oncology, Immunology, Phase Ib Trial +21

Efficacy and safety of atezolizumab (atezo) and bevacizumab (bev) in a phase Ib study of microsatellite instability (MSI)-high metastatic colorectal cancer (mCRC).

Howard S. Höchster, Johanna C. Bendell, James M. Cleary et al. · Journal of Clinical Oncology · 2017 · 69 citations

Immunology, Immunoediting, Pathology +25

Association of high tissue TMB and atezolizumab efficacy across multiple tumor types.

Fatema A. Legrand, David R. Gandara, Sanjeev Mariathasan et al. · Journal of Clinical Oncology · 2018 · 57 citations

Immunology, Pathology, Oncology +16

Abstract 2651: Clinical activity and immune correlates from a phase Ib study evaluating atezolizumab (anti-PDL1) in combination with FOLFOX and bevacizumab (anti-VEGF) in metastatic colorectal carcinoma

Jeffrey J. Wallin, Michael J. Pishvaian, Genevive Hernandez et al. · Cancer Research · 2016 · 41 citations

Immunology, Immune Regulation, Pathology +23